Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.44 USD -0.91%
Market Cap: 415.5m USD
Have any thoughts about
Chromadex Corp?
Write Note

Chromadex Corp
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chromadex Corp
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Net Change in Cash
$5.6m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
47%
Thermo Fisher Scientific Inc
NYSE:TMO
Net Change in Cash
-$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Danaher Corp
NYSE:DHR
Net Change in Cash
-$9.7B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Net Change in Cash
$1.9m
CAGR 3-Years
-60%
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Agilent Technologies Inc
NYSE:A
Net Change in Cash
-$261m
CAGR 3-Years
N/A
CAGR 5-Years
21%
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Net Change in Cash
$348m
CAGR 3-Years
287%
CAGR 5-Years
57%
CAGR 10-Years
26%
No Stocks Found

Chromadex Corp
Glance View

Market Cap
413.6m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

What is Chromadex Corp's Net Change in Cash?
Net Change in Cash
5.6m USD

Based on the financial report for Sep 30, 2024, Chromadex Corp's Net Change in Cash amounts to 5.6m USD.

What is Chromadex Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
47%

Over the last year, the Net Change in Cash growth was -58%. The average annual Net Change in Cash growth rates for Chromadex Corp have been -32% over the past three years , and 47% over the past ten years .

Back to Top